GGrantIndex
Sort

141,003 grants matching cytokine

Mechanisms of varicella virus-induced multisystem disease using a primate model

$1,019,143
Ravi Mahalingam · University Of Colorado Denver · P01 · FY2020 · AG

CELL THERAPY CORE

$1,019,060
Michael I Nishimura · Loyola University Chicago · P01 · FY2014 · CA

Alternatively activated macrophages during type 2 immune responses

$1,018,690
P'ng Loke · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Regulation of mucosal immune responses by helminth infections

$1,018,690
P'ng Loke · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Clinical Proteomics and Laser Capture Microdissection

$1,018,608
Elaine S Jaffe · Basic Sciences · Z01 · FY2007 · CA

A New Small-Molecule Kinase Inhibitor for Airway Disease

$1,018,383
Kay O Broschat · Nupeak Therapeutics, Inc. · R42 · FY2024 · HL

Transcriptional Regulation of Immune Cell Development, Activation and Functions

$1,018,340
Jinfang Zhu · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid Antigens

$1,018,336
Chetan Seshadri · University Of Washington · R01 · FY2016 · AI

Clinical Trials of Patients with AIDS-Related Malignancies

$1,018,235
Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Genetics, Natural History, and Pathophysiology of Behcet's Disease

$1,018,179
Daniel Kastner · National Human Genome Research Institute · ZIA · FY2014 · HG

Genetics, Pathophysiology, and Treatment of Recessive Autoinflammatory Diseases

$1,018,179
Daniel Kastner · National Human Genome Research Institute · ZIA · FY2014 · HG

Animal models of eye diseases

$1,018,089
Sheldon Miller · National Eye Institute · ZIA · FY2016 · EY

Testing practical microbicides in macaques

$1,017,895
Ronald S. Veazey · Weill Medical Coll Of Cornell Univ · U19 · FY2008 · AI

STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY - In vitro

$1,017,885
Florence Burleson · Brt-Burleson Research Technologies, Inc. · N01 · FY2019 · ES

Protection Against Inhalation Anthrax with Inactivated Spores

$1,017,835
Donald G. Guiney · University Of California, San Diego · U01 · FY2012 · AI

Understanding the Role of the Host Response in HIVSIV Infection

$1,017,478
Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Safety and Tolerability Studies for an Anti-Fibrin P2 Monoclonal Antibody for the Treatment of Alzheimer's Disease

$1,017,452
Jeffrey Stavenhagen · Therini Bio, Inc. · U01 · FY2022 · AG

Exisulind for Chemoprevention of Lung Cancer

$1,017,332
H. Lee Moffitt Cancer Ctr &Res Inst · U01 · FY2005 · CA

Opiate drug abuse and CNS vulnerability to HIV

$1,017,092
Kurt Francis Hauser · Virginia Commonwealth University · P01 · FY2009 · DA

Systemic regulation of metastasis

$1,017,000
David Charles Lyden · Weill Medical Coll Of Cornell Univ · R35 · FY2018 · CA

Systemic regulation of metastasis

$1,017,000
David Charles Lyden · Weill Medical Coll Of Cornell Univ · R35 · FY2021 · CA

Toxicology in the 21st Century Program (Tox21) - Systems Toxicology

$1,016,978
Menghang Xia · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR

AUTOIMMUNITY CENTERS OF EXCELLENCE

$1,016,892
Columbia University Health Sciences · U19 · FY2001 · AI

Transforming Dialysis into a Controlled Drug Delivery System for Stem Cell Derive

$1,016,886
Arno W Tilles · Sentien Biotechnologies, Inc. · R44 · FY2014 · DK

MOLECULAR AND CELLULAR MECHANISMS OF OSTEOPOROSIS

$1,016,767
University Of Arkansas Med Scis Ltl Rock · P01 · FY2000 · AG